Target intelligence / Profile preview

Interferon gamma receptor complex (includes subunits IFNGR1 and IFNGR2) (IFNGR complex (subunits commonly abbreviated as IFNGR1 and IFNGR2))

Target
IFNGR complex (subunits commonly abbreviated as IFNGR1 and IFNGR2)
Molecular classification
Receptor, Cytokine receptor, Type II cytokine receptor, Integral membrane protein
01

Overview

The interferon gamma receptor complex is the cellular receptor for interferon gamma (IFN-γ), consisting of two non-preassociated subunits: IFNGR1 and IFNGR2. Upon IFN-γ binding, the complex forms a ligand-induced assembly of two IFNGR1 and two IFNGR2 molecules, bringing together their intracellular domains and constitutively associated Janus kinases (Jak1 and Jak2). This triggers phosphorylation of IFNGR1, recruitment and phosphorylation of STAT1, and gene regulatory activity essential for innate and adaptive immune responses, including upregulation of major histocompatibility complex molecules and activation of macrophages. Defects in either receptor subunit lead to profound immune impairment, particularly in defense against intracellular pathogens, and the receptor’s signaling dynamics are being explored for immunotherapeutic and anti-inflammatory interventions.

Other names
Interferon gamma receptorIFN-γ receptorIFNGRType II interferon receptor
02

Mechanism of action

Ligand binding induces receptor dimerization, recruitment and activation of Janus kinases (Jak1 and Jak2), and subsequent phosphorylation and dimerization of STAT1, resulting in transcriptional activation of target genes. Some drugs/variants seek selective signaling outcomes by modulating receptor agonism or antagonism.

03

Biological functions

Signal transductionImmune response (including coordination of innate and adaptive immunity)Regulation of gene expression, particularly immediate-early IFN-γ-inducible genes
04

Disease associations

Infection (especially susceptibility to mycobacterial disease syndromes, e.g., Mendelian susceptibility to mycobacterial disease)Inflammation (regulation of pro-inflammatory and anti-inflammatory responses)Cancer (immune surveillance, immunotherapy trial designs)Autoimmune disease (dysregulation contributes to autoimmunity)
05

Safety considerations

Therapeutic use of IFN-γ or strong receptor agonists can induce excessive inflammation, cytopenias, autoimmunity, or flu-like toxicitiesLoss-of-function mutations result in susceptibility to infections, notably by mycobacteriaImmunosuppression may occur in cancer therapy designs
06

Interacting drugs

Recombinant interferon gamma (IFN-γ)

1 more in the full profile.

07

Biomarkers

Cell-surface expression of IFNGR1/IFNGR2 (potential diagnostic or prognostic marker)STAT1 phosphorylation (marker for pathway activation and efficacy monitoring)

Beyond the preview

Go deeper on Interferon gamma receptor complex (includes subunits IFNGR1 and IFNGR2) (IFNGR complex (subunits commonly abbreviated as IFNGR1 and IFNGR2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon gamma receptor complex (includes subunits IFNGR1 and IFNGR2) (IFNGR complex (subunits commonly abbreviated as IFNGR1 and IFNGR2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call